TURKISH JOURNAL OF GASTROENTEROLOGY, vol.25, no.2, pp.198-204, 2014 (SCI-Expanded)
Background/Aims: We aimed to investigate the efficacy and tolerability of a FOLFOX7 regimen in the first-line treatment of metastatic colorectal cancer (mCRC) patients.